º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Economic Development

Birmingham Post Rich List 2016: No.37 - Jo Bradwell

Professor Bradwell founded Birmingham-based medical diagnostics company Binding Site in 1983

Sir Adrian Cadbury, Sir Dominic Cadbury and Prof Jo Bradwell at The Binding Site after winning a Queens Award in 2007

Pharmaceuticals
2016: No.37 £105m
2015: No.34 £105m

has a pioneering centre to lead research into the world’s forests, funded by a £15 million donation from former student and academic entrepreneur and his wife Barbara. It’s one of the largest gifts ever given to a British university.

The Institute for Forest Research will study the impact of climate and environmental change on woodlands and the resilience of trees to pests and diseases.

Professor Bradwell, who studied medicine at the university and graduated in 1968, subsequently becoming a professor in the Department of Immunology said, “The º£½ÇÊÓÆµ has the lowest woodland cover of any large European country because of deforestation over the centuries. What little we have remaining is now under serious threat from climate change and imported tree diseases. The new forestry institute will increase our understanding of these challenges in order to help planners, owners and foresters maintain and improve the health of our woods.”

Professor Bradwell founded Birmingham-based medical diagnostics company Binding Site in 1983. It is a classic example of how discoveries in the laboratory can achieve considerable commercial success.

The company was spun out of research work undertaken at the University of Birmingham The team developed a new way to produce highly sensitive antibodies which could be used for diagnostic tests to identify childhood immune deficiencies and blood cancers in adults. Realising they had identified a process with huge commercial potential internationally the research team, led by Professor Jo Bradwell created the Binding Site as a commercial venture.

That was more than 30 years ago. In November 2011, Prof Bradwell sold the majority of the shares in the medical diagnostics company to private investment group Nordic Capital. Jo Bradwell retains a small shareholding and remains on the board. The value of the sale is undisclosed, but it will have been a considerable sum. In 2009, Binding Site’s auto-immune operation was sold to the Werfen Group for £80 million.

Jo Bradwell, 70, remains a professor at Birmingham University and is still involved in research. The Binding Site leases laboratories from the University and does much of its work there. Its headquarters is a state-of-the-art research facility in the heart of Edgbaston’s medical quarter in Calthorpe Road. Employing 630 people, the company has offices and distributors all over the globe, with a major operation in San Diego, USA. It turns over £71 million a year, most of which is export based.